Minnetronix’s Neuro division said today they completed the first trial of its Neurapheresis Therapy system exploring its use in treating patients suffering from aneurysmal subarachnoid hemorrhage.
The company’s Neurapheresis Therapy system is a minimally invasive platform which includes a dual lumen catheter designed to be placed in the lumbar spine to filter contaminated cerebral spinal fluid to remove blood and blood breakdown byproducts, the St. Paul, Minn.-based company said. The system then returns clean cerebral spinal fluid to the patient.
Read the whole story on our sister site, Medical Design & Outsourcing
The post Minnetronix touts completion of Neurapheresis hemorrhagic stroke trial appeared first on MassDevice.
from MassDevice https://ift.tt/2DMA5cq
Cap comentari:
Publica un comentari a l'entrada